Gavin Dabrera

15.4k citations

61 papers · 3.2k indexed · 2 hit papers · h-index 17

Impact in

Modeling and Simulation top 0.2%
- COVID-19 epidemiological studies
Infectious Diseases top 0.5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing

Papers in ⓘ

Infectious Diseases 30
- SARS-CoV-2 and COVID-19 Research 17
- SARS-CoV-2 detection and testing 12
- COVID-19 Clinical Research Studies 12
- Viral Infections and Vectors 4
Epidemiology 17
- Influenza Virus Research Studies 11

Co-authors: Mary Ramsay (7 shared papers)Jamie Lopez Bernal (10 shared papers)Gayatri Amirthalingam (4 shared papers)Simon Thelwall (8 shared papers)Eileen Gallagher (5 shared papers)Natalie Groves (7 shared papers)Maria Zambon (3 shared papers)Nick Andrews (7 shared papers)
Journals: Epidemiology and Infection (8 papers)Eurosurveillance (6 papers)Public Health (5 papers)Influenza and Other Respiratory Viruses (4 papers)The Journal of Infectious Diseases (4 papers)
Partner nations: United Kingdom Sweden Maldives

In The Last Decade

Gavin Dabrera

59 papers receiving 3.1k citations

Hit Papers

align trajectories log scale

Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study 2021 · 372 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2021 Cronfa (Swansea University)
2021 New England Journal of Medicine

Peers

Countries citing papers authored by Gavin Dabrera

Since Specialization

Citations

This map shows the geographic impact of Gavin Dabrera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gavin Dabrera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gavin Dabrera more than expected).

Fields of papers citing papers by Gavin Dabrera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gavin Dabrera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gavin Dabrera. The network helps show where Gavin Dabrera may publish in the future.

Co-authors

The 25 scholars most cited alongside Gavin Dabrera, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gavin Dabrera Line = papers co-authored together Gavin Dabrera links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant New England Journal of Medicine ·Jamie Lopez Bernal, Nick Andrews, Charlotte Gower, Eileen Gallagher, Ruth Simmons, Simon Thelwall, Julia Stowe, Elise Tessier, Natalie Groves, Gavin Dabrera, Richard Myers, Colin Campbell, Gayatri Amirthalingam, Matt Edmunds, Maria Zambon, Kevin Brown, Susan Hopkins, Meera Chand, Mary Ramsay Hit paper breakdown →	2021	1738
2	Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study Cronfa (Swansea University) ·Katherine A. Twohig, Tommy Nyberg, Asad Zaidi, Simon Thelwall, Mary Sinnathamby, Shirin Aliabadi, Shaun R. Seaman, Ross Harris, Russell Hope, Jamie Lopez Bernal, Eileen Gallagher, André Charlett, Daniela De Angelis, Anne M. Presanis, Gavin Dabrera Hit paper breakdown →	2021	372
3	A Case-Control Study to Estimate the Effectiveness of Maternal Pertussis Vaccination in Protecting Newborn Infants in England and Wales, 2012-2013 Clinical Infectious Diseases ·Gavin Dabrera, Gayatri Amirthalingam, Nick Andrews, Helen Campbell, Steve Biko Menezes Hora Alves Ribeiro, Edna Kara, Norman K. Fry, Mary Ramsay	2014	282
4	Household transmission of COVID-19 cases associated with SARS-CoV-2 delta variant (B.1.617.2): national case-control study The Lancet Regional Health - Europe ·Hester Allen, Amoolya Vusirikala, Joe Flannagan, Katherine A. Twohig, Asad Zaidi, Dimple Chudasama, Theresa Lamagni, Natalie Groves, Charlie Turner, Christopher Rawlinson, Jamie Lopez Bernal, Ross Harris, André Charlett, Gavin Dabrera, Meaghan Kall	2021	131
5	Risk of hospital admission for patients with SARS-CoV-2 variant B.1.1.7: cohort analysis Apollo (University of Cambridge) ·Tommy Nyberg, Katherine A. Twohig, Ross Harris, Shaun R. Seaman, Joe Flannagan, Hester Allen, André Charlett, Daniela De Angelis, Gavin Dabrera, Anne M. Presanis	2021	85
6	Effectiveness of seasonal influenza vaccination during pregnancy in preventing influenza infection in infants, England, 2013/14 Eurosurveillance ·Gavin Dabrera, Hongxin Zhao, Nick Andrews, Fateha Begum, H K Green, Joanna Ellis, K.M. Elias, Matthew Donati, Maria Zambon, Richard Pebody	2014	59
7	Thunderstorm asthma: an overview of the evidence base and implications for public health advice QJM ·Gavin Dabrera, Virginia Murray, Jean Emberlin, J G Ayres, Chris Collier, Yolanda Clewlow, Patrick Sachon	2012	43
8	Long-Term Health-Related Quality of Life in Non-Hospitalized Coronavirus Disease 2019 (COVID-19) Cases With Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in England: Longitudinal Analysis and Cross-Sectional Comparison With Controls Clinical Infectious Diseases ·Frank Sandmann, Elise Tessier, Joanne Lacy, Meaghan Kall, Edwin van Leeuwen, André Charlett, Rosalind M. Eggo, Gavin Dabrera, W. John Edmunds, Mary Ramsay, Helen Campbell, Gayatri Amirthalingam, Mark Jit	2022	36
9	Timeliness and completeness of laboratory-based surveillance of COVID-19 cases in England Public Health ·Tom Clare, Katherine A. Twohig, Anne Marie O’Connell, Gavin Dabrera	2021	33
10	An outbreak caused by the SARS-CoV-2 Delta (B.1.617.2) variant in a care home after partial vaccination with a single dose of the COVID-19 vaccine Vaxzevria, London, England, April 2021 Eurosurveillance ·Sarah Williams, Amoolya Vusirikala, Shamez Ladhani, Elena Fernandez Ruiz De Olano, Nalini Iyanger, Felicity Aiano, Kelly Stoker, G. Gopal Rao, Laurence John, Bharat Patel, Nick Andrews, Gavin Dabrera, Mary Ramsay, Kevin Brown, Jamie Lopez Bernal, Vanessa Saliba	2021	31
11	Highly pathogenic avian influenza A(H5N8) outbreaks: protection and management of exposed people in Europe, 2014/15 and 2016 Eurosurveillance ·Cornelia Adlhoch, Ian H. Brown, Svetla Angelova, Ádám Bálint, Ruth Bouwstra, Silke Buda, Maria Rita Castrucci, Gavin Dabrera, Ádám Dán, Christian Grund, Timm Harder, Wim van der Hoek, Katalin Krisztalovics, Frances Parry‐Ford, Rodica Popescu, Anders Wallensten, Anna Zdravkova, Siamak Zohari, Svetla Tsolova, Pasi Penttinen	2016	27
12	The spatio-temporal distribution of COVID-19 infection in England between January and June 2020 Epidemiology and Infection ·Richard Elson, Tilman M. Davies, Iain Lake, Roberto Vivancos, Paula Blomquist, André Charlett, Gavin Dabrera	2021	24
13	Chlamydia screening by community pharmacists: a qualitative study: Table 1 Journal of Family Planning and Reproductive Health Care ·Gavin Dabrera, David M. Pinson, Steve Whiteman	2011	23
14	Association between use of proton pump inhibitors and non-typhoidal salmonellosis identified following investigation into an outbreak ofSalmonellaMikawasima in the UK, 2013 Epidemiology and Infection ·Rachel Freeman, Gavin Dabrera, Chris Lane, Natalie Adams, Lynda Browning, Tom Fowler, R. Gorton, Tansy Peters, Henry Mather, Philip Ashton, Tim Dallman, Gauri Godbole, D Tubin-Delic, André Charlett, M. Fisher, Goutam K. Adak	2015	21
15	Penetration and impact of COVID-19 in long term care facilities in England: population surveillance study International Journal of Epidemiology ·Dimple Chudasama, Hannah Milbourn, Olisaeloka Nsonwu, Francis Senyah, Isaac Florence, Bryony Cook, Elizabeth Marchant, Paula Blomquist, Joe Flannagan, Gavin Dabrera, James Lewis, Theresa Lamagni	2021	19
16	Hospitalisation and mortality risk of SARS-COV-2 variant omicron sub-lineage BA.2 compared to BA.1 in England Nature Communications ·Harriet Webster, Tommy Nyberg, Mary Sinnathamby, Nurin Abdul Aziz, Neil M. Ferguson, Giulia Seghezzo, Paula Blomquist, Jessica R. E. Bridgen, Meera Chand, Natalie Groves, Richard Myers, Russell Hope, Efejiro Ashano, Jamie Lopez Bernal, Daniela De Angelis, Gavin Dabrera, Anne M. Presanis, Simon Thelwall	2022	18
17	Protective Measures for Humans against Avian Influenza A(H5N8) Outbreaks in 22 European Union/European Economic Area Countries and Israel, 2016–17 Emerging infectious diseases ·Cornelia Adlhoch, Gavin Dabrera, Pasi Penttinen, Richard Pebody, (unknown)	2018	16
18	HOSTED—England’s Household Transmission Evaluation Dataset: preliminary findings from a novel passive surveillance system of COVID-19 International Journal of Epidemiology ·JA Hall, Harris Rj, Asad Zaidi, SC Woodhall, Gavin Dabrera, JK Dunbar	2021	16
19	Vaccine effectiveness against hospitalisation estimated using a test-negative case-control study design, and comparative odds of hospital admission and severe outcomes with COVID-19 sub-lineages BQ.1, CH.1.1. and XBB.1.5 in England The Lancet Regional Health - Europe ·Freja Kirsebom, Katie Harman, Rachel Lunt, Nick Andrews, Natalie Groves, Nurin Abdul Aziz, Russell Hope, Julia Stowe, Meera Chand, Mary Ramsay, Gavin Dabrera, Meaghan Kall, Jamie Lopez Bernal	2023	15
20	Comparison of the risk of hospitalisation among BA.1 and BA.2 COVID‐19 cases treated with sotrovimab in the community in England Influenza and Other Respiratory Viruses ·Katie Harman, Sophie Nash, Harriet Webster, Natalie Groves, Jo Hardstaff, Jessica R. E. Bridgen, Paula Blomquist, Russell Hope, Efejiro Ashano, Richard Myers, Sakib Rokadiya, Susan Hopkins, Colin Brown, Meera Chand, Gavin Dabrera, Simon Thelwall	2023	14

About Gavin Dabrera

Gavin Dabrera is a scholar working on Infectious Diseases, Epidemiology, Modeling and Simulation, General Health Professions and Health, Toxicology and Mutagenesis, having authored 61 papers that have together received 3.2k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (17 papers), COVID-19 epidemiological studies (17 papers), SARS-CoV-2 detection and testing (12 papers), COVID-19 Clinical Research Studies (12 papers), Influenza Virus Research Studies (11 papers), Animal Disease Management and Epidemiology (5 papers), Vaccine Coverage and Hesitancy (4 papers) and Viral Infections and Vectors (4 papers). The work is most often cited by research in Modeling and Simulation (741 citations), Infectious Diseases (2.2k citations), Health (857 citations), Microbiology (279 citations) and Epidemiology (576 citations). Gavin Dabrera has collaborated with scholars based in United Kingdom, Sweden and Maldives. Frequent co-authors include Mary Ramsay, Jamie Lopez Bernal, Gayatri Amirthalingam, Simon Thelwall, Eileen Gallagher, Natalie Groves, Maria Zambon, Nick Andrews, Elise Tessier and Meera Chand. Their work appears in journals such as Epidemiology and Infection, Eurosurveillance, Public Health, Influenza and Other Respiratory Viruses and The Journal of Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact